QA: Huntsman CORP in us_medicinal_products/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001307954_2012_Huntsman_CORP.pdf

Logs

info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME': 31, '0021 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME CALC 2': 4, '0022 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME CALC 3': 2}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001307954, Huntsman CORP

  xvar xval
0 LiabilitiesNoncurrent 4,742,000,000
1 LiabilitiesCurrent 1,826,000,000
2 remainder_Liabilities 313,000,000
3 AssetsCurrent 3,946,000,000
4 AssetsNoncurrent 684,000,000
5 PropertyPlantAndEquipmentNet 3,622,000,000
6 Goodwill 205,000,000
7 remainder_Assets 200,000,000
8 GeneralAndAdministrativeExpense 921,000,000
9 ResearchAndDevelopmentExpense 166,000,000
10 remainder_Expenses 9,886,000,000
11 remainder_Revenues 11,223,000,000
12 remainder_NetIncome 4,000,000
13 remainder_ComprehensiveNetIncome -269,000,000
  yvar yval
0 Liabilities 6,881,000,000
1 Assets 8,657,000,000
2 Expenses 10,973,000,000
3 Revenues 11,223,000,000
4 StockholdersEquity 1,776,000,000
5 NetIncome 254,000,000
6 ComprehensiveNetIncome 119,500,000
7 BaseVar 19,003,500,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.329
9 EconomicCapitalRatio 1.15

Edgar->Model Mapping

Feature Distribution

Change over Time